DMG26: A Targeted Sequencing Panel for Mutation Profiling to Address Gaps in the Prognostication of Multiple Myeloma

In this study, we examined the exonic sequences of 26 genes reported to be mutated in>1% of myeloma patients using a custom panel.

Source: Journal of Molecular Diagnostics - September 21, 2021 Category: Pathology Authors: Samuel D. Cutler, Philipp Knopf, Clinton JV. Campbell, Andrea Thoni, Mohamed Abou El Hassan, Nicholas Forward, Darrell White, Julie Wagner, Marissa Goudie, Jeanette E. Boudreau, Barry E. Kennedy, Shashi Gujar, Daniel Gaston, Manal O. Elnenaei Tags: Regular Article Source Type: research